UBS raised the firm’s price target on Travelers (TRV) to $287 from $284 and keeps a Neutral rating on the shares. Property and casualty insurance stocks underperformed in Q3, but lighter catastrophe losses support higher earnings estimates, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRV:
- Travelers price target raised to $313 from $274 at Barclays
- Travelers price target raised to $285 from $269 at Morgan Stanley
- Travelers price target lowered to $304 from $316 at Keefe Bruyette
- Travelers price target raised to $308 from $303 at Evercore ISI
- Wolfe Research launches coverage with positive view on Life Insurance names
